• 30 November 2011

    Farewell time for world’s largest selling chartbuster pharmaceutical brand Lipitor®: What next after November 30, 2011

    About Authors:
    Dr. Amit Gangwal,
    Smriti College of Pharmaceutical Education,
    Indore

    Introduction
    Lipitor® is the best-selling drug ever, accounting for $106 billion sales over the last decade. Two generic drug manufacturers are ready to compete starting December 1, 2011. Watson Pharmaceuticals is making a generic version authorized by Pfizer under a profit-sharing agreement. Pending federal approval, Ranbaxy Laboratories also plans to sell a generic version. It is noteworthy that when a drug’s patent protection expires, the federal law permits only limited generic competition in the first six months1.

  • 24 August 2011
    Quality Technician - II Require @ Merck & Co. | US-Missouri

    Merck and Schering-Plough merged in November 2009 to create a new company. Today, they are the second-largest healthcare company in the world. They also are a global leader in consumer products and animal care.

  • 21 August 2011
    Merck & Co. looking for Head Quality Assurance

    Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country.

  • 19 August 2011
    Career at Merck & Co. as a Product Manager Cardio - Metabolic Care

    Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country.

  • 26 April 2010
    Liraglutide Superior to Sitagliptin When Added to Metformin for Glycemic Control

    The addition of a glucagonlike peptide-1 (GLP-1) agonist in patients with inadequate glycemic control when treated with metformin alone resulted in significantly larger reductions in HbA1c levels when compared with the addition of a dipeptidyl peptidase-4 (DPP-4) inhibitor, a new study has shown.

Subscribe to Merck